Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
John J. NicolsPresident & CEO770,0741.95%2014-06-13
Dr. Patrick Y. Yang, PhDN/A229,5150.58%2014-11-18
Mr. Douglas T. SheehySVP, General Counsel & Sec.209,1450.53%2014-08-10
Bernard KelleyDirector160,9490.41%2014-06-11
James LalondeSVP, R&D150,2420.38%2014-08-10
Thomas R. BaruchDirector138,4510.35%2014-06-11
Mr. Byron L. DorganN/A135,9510.34%2014-06-11
Mr. Dennis P. WolfN/A135,9510.34%2014-06-11
Mr. David D. O'TooleSVP & CFO110,6870.28%2013-09-04
Dr. David L. AntonSVP, BioIndustrials93,7770.24%2013-02-10

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Yang Patrick YDirector2014-11-18Buy20,000229,515$2.354723.4Link
Yang Patrick YDirector2014-11-17Buy20,000209,515$2.3446.823.93Link
CMEA VENTURES LIFE SCIENCES 20Director, 10% Owner2014-11-10Sell2,921,2250$2.376923.322.36Link
Yang Patrick YDirector2014-08-12Buy60,000189,515$2.22133.230.63Link
NICOLS JOHN JPresident & CEO
(Click for the stocks that their CEOs have bought)
2013-03-08Buy27,000911,000$2.4265.319.83Link
NICOLS JOHN JPresident & CEO2013-03-07Buy54,000884,000$2.22119.930.63Link
O'Toole David DSVP & CFO2013-03-04Buy10,000115,384$2.0220.243.56Link
O'Toole David DSVP & CFO2012-11-12Buy5,00060,000$2.21131.82Link
O'Toole David DSVP & CFO2012-09-14Buy5,00055,000$2.7813.94.32Link
Sheehy Douglas T.SVP, General Counsel & Sec.2012-09-14Sell3,80069,200$2.7610.55.07Link
Anton David L.SVP, BioIndustrials2012-09-14Sell3,80070,200$2.7610.55.07Link
SHAW ALANPresident and CEO2011-12-16Sell53,846277,000$5.28284.3-45.08Link
SHAW ALANPresident and CEO2011-12-14Sell37,820330,846$5.27199.3-44.97Link
SHAW ALANPresident and CEO2011-07-07Sell15,000368,666$10.13152-71.37Link
SHAW ALANPresident and CEO2011-06-02Sell15,000368,666$10.39155.9-72.09Link
Lawson Robert JSVP and CFO2011-05-11Buy2,00044,000$9.519-69.47Link
SHAW ALANPresident and CEO2011-05-02Sell15,000268,666$10.44156.6-72.22Link
SHAW ALANPresident and CEO2011-04-01Sell15,000268,666$12.07181.1-75.97Link
SHAW ALANPresident and CEO2011-03-01Sell15,000218,666$10.65159.8-72.77Link
SHAW ALANPresident and CEO2011-02-11Sell15,000218,666$10.46156.9-72.28Link
BARUCH THOMAS RDirector2010-08-27Buy2,5002,742,658$7.5518.9-61.59Link
Pasternack Bruce ADirector2010-08-24Buy10,00010,000$7.7877.8-62.72Link
SHAW ALANPresident and CEO2010-08-10Buy2,00096,132$816-63.75Link
Sheehy Douglas T.SVP, Gen Counsel and Sec.2010-08-10Buy1,0001,000$7.998-63.7Link
Sarret Joseph J.CBO, President Pharmaceuticals2010-08-10Buy2,00015,333$7.9916-63.7Link
Lawson Robert JSVP and CFO2010-08-10Buy2,0002,000$816-63.75Link
Anton David L.SVP, Research and Development2010-08-10Buy2,0002,000$7.9916-63.7Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK